http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2731794-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7fd2f49025974303ee64f8c1440db42 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_049a32c30a1dcf46b354694a7a8909bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a9a12dfeae0fb32233de9e2f4cccc1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa4ee5f3eea0aaff55cc2240e7d4ad27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe6301a2bf425dc6ffbc3dfde2540174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54f8ed0280963a605dcd3679fd7c31c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01cab6ac982ce4cf839d58be88da3831 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05d67b3169564aee84915ee1a044f82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_478e3960394e9f15771fae0ddfa07ce6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6650e60b6ef38b9ff1580b9f0b202e6c |
| publicationDate | 2020-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2731794-C1 |
| titleOfInvention | Method of combined surgical treatment of macular ruptures in complicated cataract |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, particularly to ophthalmology. For combined surgical treatment of macular ruptures in complicated cataract vitrectomy is performed, removal of vitreous humor posterior hyaloid membrane, staining of macular area with dye and ILM peeling. Periphery of the capsule of the crystalline lens removed at the phacoemulsification stage is excised to the required diameter. Using endovitreal tweezers, a vitreous cavity is inserted into a formed flap of a lens capsule and placed on the surface of the macular area, covering the rupture zone. For reliable attachment of the flap to the central area of the retina, PFOC is used, which is introduced from the center, onto the flap surface, covering the macular area, with further filling of the vitreal cavity. In the PFOC medium, the graft is centered above the macular rupture. After PFOC removal, the vitrarium cavity is tamponaded with sterile air and/or gas-air mixture.EFFECT: method provides achieving a high and stable morphofunctional result on a postoperative posterior segment of the eyeball, particularly in a central retinal area, in one surgical intervention, preventing recurrent macular ruptures in the early and remote postoperative periods.1 cl, 1 ex, 2 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2784954-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2794859-C1 |
| priorityDate | 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.